Table 1 Clinical characteristics of patients.
From: Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis
Cohort | GSE32062 | GSE26712 | GSE17260 | |
|---|---|---|---|---|
Total number | 260 | 185 | 110 | |
Age (mean ± SD) | 58.2 ± 10.8 | 62 ± 12 | 59 ± 12.6 | |
Histology | Serous | 260 (100%) | 166 (89.73%) | 110 (100%) |
Others | 0 | 19 (10.27%) | 0 | |
Stage | Stage I | 0 | 0 | 0 |
Stage II | 0 | 0 | 0 | |
Stage III | 204 (78.46%) | 144 (77.84%) | 93 (84.55%) | |
Stage IV | 56 (21.54%) | 41 (22.16%) | 17 (15.45%) | |
Grade | Grade 1 | 0 | 0 | 26 (23.64%) |
Grade 2 | 131 (50.38%) | 40 (21.62%) | 41 (37.27%) | |
Grade 3 | 129 (49.62%) | 144 (77.84%) | 43 (39.09%) | |
Grade 4 | 0 | 1 (0.54%) | 0 | |
Treatment | Platinum | 260 (100%) | 185 (100%) | 110 (100%) |
Taxane | 260 (100%) | 185 (100%) | 110 (100%) | |
OS (median (interquartiles)) | 41.5 (1128) months | 3.19 (0.06,13.65) years | 30.5 (1,81) months | |